The prevalence of dermatophytes and yeasts (Candida spp. and Pityrosporum spp.) was studied in 40 former drug-addicts, all of whom were HIV seropositive but otherwise had no other symptoms (2nd Stage CDC Atlanta, 1987). We considered 7 skin areas for dermatophytes and Pityrosporum spp. (scalp, forehead, nose, back, chest, groin, toe webs) and the mouth for yeasts. Dermatophytes were found in 8 (20%) and tinea pedis was the most common dermatophytosis: Tricophyton rubrum was the fungus most frequently isolated (6 cases or 15%). The HIV + group showed almost the same rate of dermatophytes colonisation compared to a group of 121 athletes and to the control group. Candida spp. was present in 27 cases (67.5%) but clinical oral lesions were evident only in 5 patients (12.5%). Statistically significant differences were found in the presence of Candida spp. in HIV patients and controls (p<0.05). The lipophilic yeast Pityrosporum ovale was evaluated with quantitative and qualitative methods. Quantitative variations were evident between HIV patients and controls. P. ovale was present in 10 cases: 3 (7.5%) of them showed dischromic lesions while in 7 cases (17.5%) no clinical symptoms were evident.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Torsander J, Karlson A, Morfeld-Manson L, Putkonen PO, Wasserman J. Dermatophytosis and HIV infection. Acta Derm Venereol (Stockh) 1988; 68: 53–6.
Torsander J, Morfeld-Manson L, Biberfeld G, Karlson A, Putkonen PO, Wasserman J. Oral Candida albicans in HIV infection. Scand J Infect Dis 1987; 19: 291–5.
Badillet G, Traore F. Dermatophytes et serologie HIV positive. Bull Soc Fr Mycol Med 1987; 16(1): 95–8.
Klein RS, Harris CA, Moll B, Lesser M, Friedland G. Oral candidiasis in high-risk patients as the initial manifestation of the Acquired Immunodeficiency Syndrome. N Engl J Med 1984; 311: 354–8.
De Vroey C, Song M. Dermatophytes and Pityrosporum in AIDS patients ecology and epidemiology. Abstracts of 3rd Symposium Mycoses in AIDS Patients. The Pasteur Institute Nov. 20–23 1989, Paris.
Hanifin JM, Ray LF, Lobitz WC. Immunological reactivity in dermatophytosis. Br J Dermat 1974; 90: 1–7.
Faergeman J, Aly R, Maibach HI. Quantitative variations in distribution of Pityrosporum orbiculare on clinically normal skin. Acta Derm Vener (Stockh) 1986; 63: 346.
Faergeman J, Maibach HI. The Pityrosporum yeasts: their role as pathogens. Int J Dermat 1984; 23: 463–5.
Hay RJ. Clinical aspect of dermatomycoses in AIDS patients. The Pasteur Institute Nov. 20–23, 1989, Paris.
Di Silverio A, Senaldi G, Di Pieri G, Minoli L. Seborrheic dermatitis: an early manifestation in AIDS. Clin Exp Derm 1987; 12: 72.
Mathes Barbara MMD, Douglas CMD. Seborrheic Dermatitis in patients with Acquired Immunodeficiency Syndrome. J Am Acad Dermat 13: 947–51.
Yohn JJ, Lucas J, Camisa C. Malassezia folliculitis in immunocompromised patients. Cutis 1985; 35: 536–38.
Gueho E, Simmons RB, Ahearn DG. Malassezia spp. et infections systematiques. Bull Soc Fr Mycol Med 1987; 16: 329–32.
Wallace M, Bagnali H, Glen D, Averill S. Isolation of Lipophilic yeasts in ‘sterile’ peritonitis. Lancet 1979; 76: 112–16.
Boardman CR, Malkinson FD. Tinea versicolor in steroid treated patients. Arch Dermat 1962; 85: 84–92.
Rebell G, Taplin D. Dermatophytes. Their recognition and identification. Coral Gable: University of Miami Press, 1970.
Vermander F, De Vroey C. Denombrement de Pityrosporum ovale par empreinte directe. Bull Soc Fr Mycol Med 1985; 14(1): 23–6.
About this article
Cite this article
Di Silverio, A., Brazzelli, V., Brandozzi, G. et al. Prevalence of dermatophytes and yeasts (Candida spp., Malassezia furfur) in HIV patients. Mycopathologia 114, 103–107 (1991). https://doi.org/10.1007/BF00436429
- HIV patients